PRICE T ROWE ASSOCIATES INC /MD/ - DYNE THERAPEUTICS INC ownership

DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 70 filers reported holding DYNE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of DYNE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,572
+1167.7%
175,387
+1502.7%
0.00%
Q2 2023$124
-96.3%
10,943
-96.2%
0.00%
-100.0%
Q1 2023$3,357
+641.1%
291,310
+645.5%
0.00%
Q4 2022$453
-99.9%
39,078
+1.0%
0.00%
Q3 2022$493,000
+96.4%
38,708
+5.9%
0.00%
Q2 2022$251,000
-28.5%
36,560
+0.3%
0.00%
Q1 2022$351,000
-17.4%
36,458
+2.0%
0.00%
Q4 2021$425,000
-28.0%
35,758
-1.7%
0.00%
Q3 2021$590,000
-94.2%
36,358
-92.5%
0.00%
-100.0%
Q4 2020$10,184,000
+2.6%
484,952
-1.3%
0.00%0.0%
Q3 2020$9,923,000491,4710.00%
Other shareholders
DYNE THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 4,951,303$103,977,00014.71%
Vida Ventures Advisors, LLC 2,960,046$62,161,00012.76%
Octagon Capital Advisors LP 481,538$10,112,0003.50%
Logos Global Management LP 1,604,392$33,692,0002.89%
RA Capital Management 2,805,045$58,906,0000.82%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 12,048$253,0000.40%
HighVista Strategies LLC 23,760$499,0000.32%
Vivo Capital, LLC 315,000$6,615,0000.30%
Woodline Partners LP 490,986$10,311,0000.27%
EcoR1 Capital, LLC 215,000$4,515,0000.24%
View complete list of DYNE THERAPEUTICS INC shareholders